Skip links

JASCAYD® (nerandomilast)

Full Name JASCAYD® (nerandomilast)
Drug nerandomilast
Manufacturer Boehringer Ingelheim
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of idiopathic pulmonary fibrosis in adult patients
Disease Idiopathic pulmonary fibrosis (IPF)
Therapeutic Area Pulmonology
Enrollment Form Link Enrollment Form
Phone Number 847-239-5646
Fax Number 847-423-6217
Product Website jascayd.com